Adagene First Half 2024 Earnings: US$0.39 loss per share (vs US$0.094 loss in 1H 2023)

Simply Wall St.07-28

Adagene (NASDAQ:ADAG) First Half 2024 Results Key Financial Results Net loss: US$17.0m (loss widened by 314% from 1H 2023). US$0.39 loss per share (further deteriorated from US$0.094 loss in 1H 2023)...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2454253145?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","is_english":true,"pubTime":"2024-07-28 21:26","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2454253145","market":"us","top_or_hot":-1,"title":"Adagene First Half 2024 Earnings: US$0.39 loss per share (vs US$0.094 loss in 1H 2023)","media":"Simply Wall St.","content":"<div>\n<p>Adagene (NASDAQ:ADAG) First Half 2024 Results\nKey Financial Results\n\nNet loss: US$17.0m (loss widened by 314% from 1H 2023).\nUS$0.39 loss per share (further deteriorated from US$0.094 loss in 1H 2023)...</p>\n\n<a href=\"https://finance.yahoo.com/news/adagene-first-half-2024-earnings-132640154.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Adagene First Half 2024 Earnings: US$0.39 loss per share (vs US$0.094 loss in 1H 2023)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdagene First Half 2024 Earnings: US$0.39 loss per share (vs US$0.094 loss in 1H 2023)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-28 21:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/adagene-first-half-2024-earnings-132640154.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Adagene (NASDAQ:ADAG) First Half 2024 Results\nKey Financial Results\n\nNet loss: US$17.0m (loss widened by 314% from 1H 2023).\nUS$0.39 loss per share (further deteriorated from US$0.094 loss in 1H 2023)...</p>\n\n<a href=\"https://finance.yahoo.com/news/adagene-first-half-2024-earnings-132640154.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ADAG","symbol_name":"天演药业","start_time":0,"source_url":"https://finance.yahoo.com/news/adagene-first-half-2024-earnings-132640154.html","article_id":"2454253145","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2454253145","pubTimestamp":1722173200,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"NasdaqGM:ADAG Earnings and Revenue Growth July 28th 2024. All figures shown in the chart above are for the trailing 12 month  period. Looking ahead, revenue is forecast to grow 55% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Biotechs industry in the US.The company's share price is broadly unchanged from a week ago.You should always think about risks. Case in point, we've spotted   4 warning signs for Adagene  you should be aware of, and 2 of them shouldn't be ignored.Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ADAG":"天演药业"},"translate_title":"Adagene 2024年上半年收益：美国每股亏损0.39美元（美国2023年上半年亏损0.094美元）","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADAG":1},"content_text":"Adagene (NASDAQ:ADAG) First Half 2024 Results\nKey Financial Results\n\nNet loss: US$17.0m (loss widened by 314% from 1H 2023).\nUS$0.39 loss per share (further deteriorated from US$0.094 loss in 1H 2023).\n\n\n\n\n  NasdaqGM:ADAG Earnings and Revenue Growth July 28th 2024\n \n\nAll figures shown in the chart above are for the trailing 12 month (TTM) period\nAdagene Earnings Insights\n Looking ahead, revenue is forecast to grow 55% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Biotechs industry in the US. \nPerformance of the American Biotechs industry.\n The company's share price is broadly unchanged from a week ago. \nRisk Analysis\n You should always think about risks. Case in point, we've spotted   4 warning signs for Adagene  you should be aware of, and 2 of them shouldn't be ignored. \nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2454253145"}